Location History:
- Bordeaux, FR (2017)
- Merignac, FR (2020)
Company Filing History:
3 out of 1,745 
3 out of 212 
2 out of 26 
Years Active: 2017-2020
Title: Khalid Oumzil: Innovator in Therapeutic Agent Transportation
Introduction
Khalid Oumzil is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of three patents to his name, Oumzil's work focuses on enhancing the delivery of therapeutic agents.
Latest Patents
Oumzil's latest patents include innovative nucleoside-lipid compounds featuring pH-sensitive dialkylorthoester chains. These compounds are designed for the transportation or vectorization of therapeutic agents, showcasing a new approach to drug delivery. Another significant patent involves hydrophobically modified antisense oligonucleotides, which are modified by substituting at the 3' or 5' end with moieties that contain multiple hydrocarbon chains. This invention aims to improve the efficacy of treatments, particularly in cancer therapy.
Career Highlights
Throughout his career, Khalid Oumzil has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Bordeaux. His research has contributed to advancements in the field of drug delivery systems, making a positive impact on therapeutic strategies.
Collaborations
Oumzil has collaborated with notable colleagues, including Philippe Barthelemy and Palma Rocchi. These partnerships have fostered a collaborative environment that enhances the innovation process in his research endeavors.
Conclusion
Khalid Oumzil's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic agent transportation and delivery systems.